Markets
BSE See NSE See 39,046.34
85.55 (0.22%)
collapse Related Readings collapse

Greater risk with lesser reward

| 2/23/2012 9:38 PM Thursday

There is some disconnect between the rally in the market and India Inc.’s performance for the December 2011 quarter. While the Sensex has gone up by 19.24 per cent on a year-to-date basis, India Inc.’s report card for the quarter ended December 2011 does not paint a healthy picture, with the bottomline growing negatively. So, why this disconnect? Since the stock indices are the leading indicators, are they suggesting that all the bad news is now behind us and that the future is bright and shining? Well, when we scan through the economic data and the political scenario, there is nothing that clearly suggests that the bad news flows are indeed history.

We understand that the global economy is limping back to normalcy, and there are pockets indicating that the scenario is not that bad. Certain leading economies like the US are doing well. The Greek bailout package is also a good sign, and has helped in reducing anxiety on the Euro zone front. The Dow crossing 13000 (intra-day) after many years and the Japanese Nikkei witnessing a surge are indications that equity as an asset class is back in demand. India is also attracting good FII inflows, suggesting that the economy is back on the growth path.

However, India still needs to grapple with the problem of fiscal deficit and the lack of reforms. The political situation continues to remain fragile, and the result of the elections in UP would give some sense of political stability or instability at the centre. The way the government handled the latest NCTC issue gives a clear indication that it has not learnt any lessons from its past mistakes.

We are of the opinion that the Union Budget 2012 needs to take some hard steps to keep the economy rolling, and one of the big decisions would be to keep subsidies under control. Also, the economy needs some push, as the momentum that was built is not there anymore. Our sense is that the domestic scenario would continue to hamper the sentiment for the time being, and the market cannot afford to miss that for long. Crude prices surging would take the inflation numbers on the higher side. We strongly believe that the risk versus reward ratio is not in favour of reward. Hence, we suggest that our readers should take some profits off the table.

Our cover story for this issue has finely analysed the December 2011 quarter performance of India Inc. Our Core Research Unit has analysed the results of 3704 companies, where India Inc. has shown a growth of 23 per cent in sales but the net profit has declined by 7.2 per cent. In fact, while analysing the September 2011 quarter numbers, DSIJ had predicted (correctly, once again) that the net profit number for the December 2011 quarter would be lower than that in the corresponding period last year. This time too, our cover story has analysed 12 critical sectors with clear cut guidance on how each of them would fare in the next quarter.

I am happy to inform you that your favourite magazine, Dalal Street Investment Journal, has launched Portfolio Advisory Service 3.0 to help you play the market volatility better. PAS 3.0 comes with a whole host of new, value-added features. PAS was first launched in 2008, and today, it is serving a strong number of 600 customers all across the country with its finely crafted strategy to create an Alpha for its customers.

 

Find More Articles on: DSIJ Magazine, Editorial, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

MIDHANI and HAL partner to develop bio implants

Geyatee Deshpande / Article rating: 5.0

Mishra Dhatu Nigam Limited (MIDHANI) signs an MoU with Hindustan Antibiotics Limited (HAL). This MoU will provide synergy for quality manufacturing of MIDHANI’s Bio-medical Implants and get access to the pan-India distribution of HAL. This partnership is aimed to gain advantage from the strengths of both the companies and benefit users of Bio-medical products in India.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.